创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels: Features of Host-Versus-Graft-Generation (HVG) Evaluation Platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-06 14:47
  • Views:

(Summary description)With the rapid development of biotechnology and continuous breakthroughs in the field of medicine, the host-versus-graft (HVG) response has become an important indicator of the quality of grafts and the effectiveness of treatment. The host-versus-graft (HVG) evaluation platform launched by InnoModels Biotechnology provides researchers with a one-stop evaluation solution with its unique technological advantages and high degree of accuracy

InnoModels: Features of Host-Versus-Graft-Generation (HVG) Evaluation Platform

(Summary description)With the rapid development of biotechnology and continuous breakthroughs in the field of medicine, the host-versus-graft (HVG) response has become an important indicator of the quality of grafts and the effectiveness of treatment. The host-versus-graft (HVG) evaluation platform launched by InnoModels Biotechnology provides researchers with a one-stop evaluation solution with its unique technological advantages and high degree of accuracy

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-06 14:47
  • Views:
Information

With the rapid development of biotechnology and continuous breakthroughs in the field of medicine, the host-versus-graft (HVG) response has become an important indicator of the quality of grafts and the effectiveness of treatment. The host-versus-graft (HVG) evaluation platform launched by InnoModels Biotechnology provides researchers with a one-stop evaluation solution with its unique technological advantages and high degree of accuracy.
Highly simulated environment
InnoModels Bio's HVG evaluation platform is equipped with a highly simulated simulation environment, which can mimic the immune response process in real human body. This feature makes the evaluation results closer to the actual situation and provides researchers with more accurate experimental data.

 


Advanced Technical Support
The platform adopts advanced biotechnological means, including gene editing, cell culture, flow cytometry analysis, etc., to ensure the accuracy and reliability of the experimental process. At the same time, combined with big data analysis technology, the experimental results can be mined in depth, providing researchers with more comprehensive information support.
Personalized Customized Service
InnoModels Bio's HVG evaluation platform provides personalized customization services, tailoring experimental solutions according to customers' specific needs and research objectives. This service model not only meets the individual needs of customers, but also improves the relevance and practicality of experiments.
Rich experimental model library
The platform has a rich library of experimental models covering a wide range of graft types and host backgrounds, providing researchers with a rich choice of options. This allows researchers to choose the right model for their experiments according to their own research directions and goals.
Professional Technical Support Team
InnoModels Biotechnology has a professional technical support team with rich experimental experience and deep professional knowledge background, which can provide timely and accurate technical support and services for customers. Whether in experimental design, experimental operation or data analysis, they can provide customers with professional guidance and assistance.
Wide range of applications
InnoModels' HVG evaluation platform can be widely used in a variety of fields, including transplantation and immunization, drug discovery, and disease treatment. Its high accuracy and reliability make the experimental results have high reference value and application prospects.
In summary, with its unique technical advantages, highly simulated simulation environment, professional technical support team, and wide range of application fields, the HVG evaluation platform of InnoModels provides researchers with an efficient and accurate evaluation tool. This platform is of high value and significance for both basic and clinical application research.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司